Anheuser-Busch InBev 2023 Projection: Even though conservatives were unhappy with Bud Light’s transgender marketing campaign, Anheuser-Busch InBev (ABI.BR) maintained their 2023 projection. Anheuser-Busch InBev maintained its 2023 projection despite these issues. After the COVID-19 pandemic, the company rebounded in China.
The world’s largest brewery’s stock opened up 2.6%. One of the best-performing stocks in the FTSEurofirst 300 index (.FTEU3), including Europe’s top stocks, was 52.40 euros. A.B. InBev, which sells 25% of the world’s beer, lost 1.4% in the second quarter. Because costs changed and clients bought more expensive things, prices grew 9.0% yearly.
EBITDA rose 5.0% from April to June. $4.91 billion. This performance exceeded the company’s 0.4% prediction. Heineken (HEIN.AS), the world’s second-largest brewer, needed better results and cut its 2023 estimate due to Vietnam’s slowing growth and price increases that affected volume. SABMiller, the world’s largest brewery, did well.
Also read: FTX Altcoins Under the Spotlight: Elon Musks Tweets and Bots in the Hot Seat
A.B. InBev’s China sales increased significantly. Sales of premium beers increased by almost 20%, while volume sales rose 11%. The outbreak increased revenue and profit. Sales and profit margins improved in critical nations like Brazil and Mexico. Europe and Colombia saw similar positive effects.
A.B. InBev’s biggest market, the U.S., was different. Constellation Brands’ (STZ.N) Modelo Especial overtook Bud Light, the company’s most popular brand. People disliked a social media promotion featuring transgender influencer Dylan Mulvaney. Bud Light shop sales have decreased by 25% since April. Recent consumer research found that 80% of respondents had positive or neutral feelings about the brand, suggesting sales have decreased.
Coors Light and Miller Lite, brewed by Molson Coors (TAP.N), Bud Light’s primary U.S. competitor, did well, while Bud Light did not. After its finest quarter since merging with Coors in 2005, Molson Coors raised its outlook.
A.B. InBev is optimistic about 2023 despite U.S. issues. The company maintains its medium-term EBITDA growth target of 4% to 8%. Revenue increase exceeds EBITDA growth.
Our Reader’s Queries
What is the forecast for Anheuser-Busch InBev?
Anheuser-Busch Inbev SA’s stock price forecast is looking positive, with 10 analysts predicting a median target of 68.00 over the next 12 months. The high estimate is 79.00, while the low estimate is 60.00. This means that the median estimate represents a 6.88% increase from the current price of 63.62. Overall, it seems that the company’s stock is expected to perform well in the coming year.
What is the future of Anheuser-Busch?
Anheuser-Busch InBev is expected to experience a significant increase in both earnings and revenue, with a projected growth rate of 12.9% and 4.2% per year, respectively. Additionally, the company’s EPS is anticipated to grow by 13.5% annually. Looking ahead, Anheuser-Busch InBev is forecast to achieve a return on equity of 10.1% within the next three years.
What is the outlook for Anheuser-Busch?
BUD stock is expected to see a significant increase in its stock price over the next 12 months, according to three stock analysts. The average forecasted price is $72.5, which represents a 10.74% increase. The lowest target is $68.5, while the highest is $79. Overall, analysts rate BUD stock as a strong buy. These price targets were last updated on Nov 29, 2023.
What is the projection for Bud stock?
Analysts predict that the average price of this stock will be $71.71, with a high forecast of $79.00 and a low forecast of $67.00. This represents a 14.10% change from the current price of $62.85.